Once Versus Twice Bisoprolol Dosage Regimen in Prevention of Atrial Fibrillation Post Coronary Artery Bypass Graft Surgery

A phase 4 trial registered on ClinicalTrials.gov. The registry status is unknown. It plans to enroll 122 participants.

Also called NCT05730413

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; no masking; primary purpose prevention
Phase
Phase 4
Enrolled
  • 122 participants (planned count) (from the registry)
Sponsor
Registry
  • NCT NCT05730413
Started
(actual) (from the registry)
Primary completion
(anticipated) (from the registry)
Completion
(anticipated) (from the registry)
Countries
Egypt (from the registry)
Registry status
  • Unknown status (from the registry)

Technical summary

Registry record NCT05730413. Randomized; no masking; primary purpose prevention. Start 2021-08-25 (actual); primary completion 2023-09 (anticipated). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Once Versus Twice Bisoprolol Dosage Regimen in Prevention of Atrial Fibrillation Post Coronary Artery Bypass Graft Surgery
Condition
Postoperative Atrial Fibrillation
Intervention (Drug)
Bisoprolol
Intervention (Drug)
Bisoprolol
Lead sponsor
Cairo University (class: other)

Record details

Record id
cardio:ct-nct05730413
Content hash
913aaa2100da9fa24eab348248be6a9ae71dfec4ad7f05fba2a69ea5b6b64d03